CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Excimer Laser +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00821236
NCT00821236Phase 4Completed

A Prospective, Multi Center Clinical Comparison of Fellow Eyes Undergoing Lasik Using the Wavelight Allegretto Wave™ Excimer Laser in One Eye and the Amo/Visx Customvue™ or the Ladarvision 4000 Excimer Laser System in the Contralateral Eye

Durrie Vision·interventional·Posted Jan 13, 2009·Updated Mar 1, 2013

In Brief

A Phase 4 clinical trial evaluating Excimer Laser, AMO/VISX CustomVue™, and 1 other intervention for Myopia and Astigmatism. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

The purpose of this study is to compare LASIK outcomes using the WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment with the AMO/VISX CustomVue™ and the LADARVision 4000 excimer laser treatment. Standard refractive outcomes such as uncorrected and best corrected visual acuity, and intended vs. achieved postoperative refractions will be evaluated; in addition, high order optical aberrations, contrast sensitivity, and topography will be measured.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Astigmatism
CountriesUnited States
CollaboratorsAlcon Research

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 13, 2009
Enrollment StartJan 1, 2009
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 17.5 years ago

Interventions

Excimer Laserdevice

WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment

AMO/VISX CustomVue™device

Excimer Laser

LADARVision 4000 excimer laserdevice

Excimer Laser